{"name":"Cambridge Antibody Technology","slug":"cambridge-antibody-technology","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CAT-8015 immunotoxin","genericName":"CAT-8015 immunotoxin","slug":"cat-8015-immunotoxin","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CAT-8015 immunotoxin","genericName":"CAT-8015 immunotoxin","slug":"cat-8015-immunotoxin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNUURLTUtQZDVaYzNVLU4zbDRIbG90SVpMWFRwRXlWLUd3eTRZUlZ1SUtPaDBfLVBwVDVwLVNiZFBlQVlqUjJtMWxBZnpNbWpZN2UzVU1jcGV5MjJhNjk1VnJUaXNNenNFZVB6ZXN3blk3Zk94QXU4Q3JzazdkYVVsQlp3RGs5TjVmZFB4U0JPRDBuQlFNTVlueDhPMWdqWUdtbnJQMUhYNjdYekhWTWJF?oc=5","date":"2026-03-31","type":"pipeline","source":"Pharmaceutical Technology","summary":"Navigating commercial gaps to supercharge the UK life sciences sector - Pharmaceutical Technology","headline":"Navigating commercial gaps to supercharge the UK life sciences sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQSlQ1VjhiV09oOXVEREYyWlYtQWIxV0d0RkFZUC1pUzlaM1lEMTl4TGlxN0hFdGZha1YzeHVBQlFjSEJxM0RjSTlwbmRTeWFDNU9rUEthNFFzY2JXelZJVHIwUUprS2d4OFEyd0h2QWNHaUZOREdDenhoODVSclpLdUEtWnVNc3BPQ3FZSmtzemZSQ2hOME54UkQ1RlF3ZmhIVjVlU0ZlMjZ5d3RVa1E?oc=5","date":"2025-10-23","type":"deal","source":"Contract Pharma","summary":"Orion Obtains Exclusive Commercial License for Abzena’s Antibody - Contract Pharma","headline":"Orion Obtains Exclusive Commercial License for Abzena’s Antibody","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5QVnVSeGtWSURqVTQ4Q0lSVEJjZVZrVlhkbW40ek1QdnZMNnc5dFhnWVVCT21USFV0VHY0TnAtZjF3V2JsYUNLOFVmMnI1cWdubjdfZkNISVByTmR2R2dHVDhscGZ5SUk?oc=5","date":"2025-10-13","type":"pipeline","source":"labiotech.eu","summary":"Cambridge’s biotech scene: The cornerstone of the UK’s Golden Triangle - labiotech.eu","headline":"Cambridge’s biotech scene: The cornerstone of the UK’s Golden Triangle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNV1EyamdtaEU4WENFVXJHVHNRMEd4S1VSQTg4emNqYmx5dGhNbWl2eUJrQXdlYkF1TDNVZXR3bWxCc19XS2NDMEluQjhyNG01cEpEeWFXYXd0YlFDU1VEUEdBcWN0cUVhT3hCZTNCQWxGc2k1Mk9TYWFtYjFQdWx5QWV0akhDV2c4eXdneTBjRVlGNEU?oc=5","date":"2025-07-23","type":"pipeline","source":"Business Weekly","summary":"Shortlist unveiled for 2025 Business Weekly Awards - Business Weekly","headline":"Shortlist unveiled for 2025 Business Weekly Awards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOdGQ0N2ZLckJGbWFrelE5LUlMR0pjWHB6d1lHTUU1ZmhicnZxRmc2OTQxZmVzTXF0MFA3Zl9JcmZsRzZCYnp5OE5ZQTA4bG0wNWtnZWtWTjZDWDNxaU5JaUgwbnVzZTJwMl9nVEVSWkVvT3ZaU0tPalNqU2pleC1RVkNVRkg?oc=5","date":"2023-12-03","type":"pipeline","source":"the-scientist.com","summary":"Phage Display: Finding the One in a Million - the-scientist.com","headline":"Phage Display: Finding the One in a Million - the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE51TTFyeVJqcHpiQW1SMm5rYzYyMGFvR0ZXZVVBNHpEMzRHYWRFTG5IckVRR0pDUEdPdGRvYkowWm1SWEhUNS1qc3lDcXEzZ3hkTm5nYms2N1RxWENjU04yMDJ4bkJycm1TWGNTcjJB?oc=5","date":"2023-08-16","type":"pipeline","source":"University of Cambridge","summary":"\"A very Cambridge story\" - University of Cambridge","headline":"\"A very Cambridge story\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPU0J0eVRHXzhPUXlwTnFvSEl5LWxnRk1sT2RjQm5STFFPa1JfeDJWZldqVUtUS3hVdmh6aXhzaDJuZURIa1c5RDRVRHJZb0hVcnZKY2kyeGx1aFJOako1REZXeGNZNTRqbC1nU3lUaTFILWVjZkxodTdyaS1WYUNoNkltM3N6dTBjbEQ1cUhn?oc=5","date":"2020-08-08","type":"pipeline","source":"PharmTech.com","summary":"Avoiding pitfalls in scaling up biopharmaceutical production - PharmTech.com","headline":"Avoiding pitfalls in scaling up biopharmaceutical production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE44VmxkTVF2eWNiSV9oaHdZbkkwNTllanpzcjFGV3pFNTRRbTdOQnNnTFF0WnlNYndha0xXb2pkb0ZPSVE2MWtwZThCSlc5UkJFdE5VN1A4d1I3czFicHc?oc=5","date":"2019-11-05","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNdnhJNFFXLURVeVR3RFNNRXNhdTRySDJJTTBzOWFMNmhPYzA5R0JILTY2TTFwS0x0ZjJhX3NKZzdmam9PUEtZYjFlOUVORlZtVEpLMzFtMmZHMk5INjlCWmRyQVRIOE5tdWUwOFlHTWs0Y2docGdvSEtsWHpmZkRFc09OVm41MjdpS3BEUmE5OEh1b0t3cUtDM0pBYl92bnpKdDlVZmFYSjhrVzJYRHluZzZSdkNSYVk4NmR0a1BZYlNSZW40MUNESzFDdFBac2xYRGsw?oc=5","date":"2018-12-12","type":"pipeline","source":"News-Medical","summary":"IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony - News-Medical","headline":"IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE5lSmQwOHBScEx6djdJeC10MlhZd1JmUGU1eDg4ODdHcWNjVUZkczZwTE5lb2xHLUo5RTcwaTUwbFBaVXZzaUI1enYtSWExV09oSFhNSE1XRHJaM1JHNVFOeVpVZVJiVW9oLWVtOTVCVkJHUEU?oc=5","date":"2017-06-08","type":"pipeline","source":"labiotech.eu","summary":"Cambridge Antibody Technology: The History of the UK’s Best Biotech - labiotech.eu","headline":"Cambridge Antibody Technology: The History of the UK’s Best Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOX25FOFZtRGZhRnlTU2s0X1JRV28zNWFfdE9pYlMtOFVFcEdCa29pVEk2OGVESDFMNWt6YTlrTDkwVlJEX0NaX0JwX3FDZEI3UkY0Z2J5eVlnaFRfVFBRTkNDY0NGYzBUU2Y3Z2VXRkJwZEQtdDZTM21yVW5QbXJOVEh3?oc=5","date":"2007-04-27","type":"pipeline","source":"Science | AAAS","summary":"Careers in biotech and pharma: The right fit - Science | AAAS","headline":"Careers in biotech and pharma: The right fit - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9jdXF0UmZYcW1aX0R6MHJ4MFhILUZ1RG4yU25GTzViYXE2U2JESzh1UTdCZ3RYLXB1STJtVDAwSFhkR3ZrYXFzYm4zcE1BczNXUlN1ZUYxZGE4OFFBTlpGbnVDcFhrYjlKb01rRkUzQUVoaE5RVmFvaTVxanM?oc=5","date":"2004-11-29","type":"pipeline","source":"cen.acs.org","summary":"Astrazeneca Inks Biologics Pact - cen.acs.org","headline":"Astrazeneca Inks Biologics Pact","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}